What is he best known for?
The fields of study he is best known for:
Virology, Immunology, Autoantibody, Antibody and Molecular biology are his primary areas of study.
His Virology research includes themes of Hypogammaglobulinemia and Immune system.
Peter D. Burbelo is studying Primary immunodeficiency, which is a component of Immunology.
His Autoantibody research is multidisciplinary, relying on both Pathogenesis, Pneumonia, Disease, Opportunistic infection and Anti-SSA/Ro autoantibodies.
Peter D. Burbelo interconnects Hepatitis C virus, Hepatitis, Hepatology, Tissue tropism and Polymerase chain reaction in the investigation of issues within Antibody.
His biological study spans a wide range of topics, including Enhancer, Gene expression, Basement membrane, Thymosin beta-4 and Base pair.
His most cited work include:
- Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. (1093 citations)
- Rac and Cdc42 Induce Actin Polymerization and G1 Cell Cycle Progression Independently of p65PAK and the JNK/SAPK MAP Kinase Cascade (531 citations)
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Virology, Antibody, Autoantibody and Antigen.
His Immunology study frequently links to other fields, such as Saliva.
His Virology study deals with Serology intersecting with Encephalitis.
The study incorporates disciplines such as Luciferase and Polymerase chain reaction in addition to Antibody.
His Autoantibody study combines topics from a wide range of disciplines, such as Internal medicine, Autoimmunity, Disease, Epitope and Opportunistic infection.
His Antigen research is multidisciplinary, incorporating perspectives in Immunoassay, Sarcoma and Kaposi's sarcoma.
He most often published in these fields:
- Immunology (50.00%)
- Virology (36.49%)
- Antibody (36.49%)
What were the highlights of his more recent work (between 2018-2021)?
- Immunology (50.00%)
- Virology (36.49%)
- Antibody (36.49%)
In recent papers he was focusing on the following fields of study:
Peter D. Burbelo spends much of his time researching Immunology, Virology, Antibody, Autoantibody and Immune system.
His study in Immunology is interdisciplinary in nature, drawing from both Asymptomatic and Saliva.
His studies deal with areas such as Fulminant and Serology as well as Virology.
He combines subjects such as Luciferase, Virus, Treatment interruption and Immunity with his study of Antibody.
His Autoantibody study integrates concerns from other disciplines, such as Internal medicine, Autoimmunity, Disease, Cohort and Bronchoalveolar lavage.
His research in Immune system intersects with topics in Autoimmune disease and Immunoprecipitation.
Between 2018 and 2021, his most popular works were:
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
- Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. (117 citations)
- Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients (67 citations)
In his most recent research, the most cited papers focused on:
Peter D. Burbelo focuses on Virology, Autoantibody, Immune system, Coronavirus and Antibody.
The Virology study combines topics in areas such as Human genome, Immunity and Immunotherapy.
His Autoantibody study is related to the wider topic of Immunology.
Peter D. Burbelo interconnects Lung, Pneumonitis and Ferritin in the investigation of issues within Immunology.
His Immune system research focuses on Luciferase and how it relates to Serology and Immunocompetence.
In his study, Pandemic is inextricably linked to Severe acute respiratory syndrome coronavirus 2, which falls within the broad field of Coronavirus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
